Novel 1,4-benzoxazine and 1,4-benzodioxine inhibitors of angiogenesis

被引：11
|
作者：
Ilic, Milos [2 ]
Ilas, Janez [2 ]
Dunkel, Petra [3 ]
Matyus, Peter [3 ]
Bohac, Andrej [4 ]
Liekens, Sandra [1 ]
Kikelj, Danijel [2 ]
机构：
[1] Catholic Univ Louvain, Rega Inst Med Res, B-3000 Louvain, Belgium
[2] Univ Ljubljana, Fac Pharm, SI-1000 Ljubljana, Slovenia
[3] Semmelweis Univ, Dept Organ Chem, H-1092 Budapest, Hungary
[4] Comenius Univ, Fac Nat Sci, Dept Organ Chem, Bratislava 84215, Slovakia
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2012年 / 58卷
关键词：
Angiogenesis; Thrombin; GPIIb/IIIa antagonist; Vascular endothelial growth factor; ANTITHROMBOTIC COMPOUNDS; THROMBIN; METASTASIS; GROWTH; MECHANISM; THERAPY; CANCER; PI-88; CELLS;
D O I：
10.1016/j.ejmech.2012.10.001
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Esters of 1,4-benzoxazine and 1,4-benzodioxine compounds 1 and 10, which combine thrombin inhibitory and GPIIb/IIIa antagonistic activity in one molecule are shown to inhibit endothelial cell migration and tube formation in vitro and angiogenesis in the chicken chorioallantoic membrane (CAM) assay. The corresponding carboxylic acids 1 (R-2 = H) and 11 were devoid of anti-angiogenic activity, most probably due to their insufficient entry into the cell. Although thrombin inhibition remains the most probable explanation for their inhibition of angiogenesis, VEGFR2 kinase assay suggest that other targets such as VEGFR2 might be involved. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：160 / 170
页数：11
相关论文
共 50 条
  • [21] New 1,4-dihydro[1,8]naphthyridine derivatives as DNA gyrase inhibitors
    Gencer, Hulya Karaca
    Levent, Serkan
    Cevik, Ulviye Acar
    Ozkay, Yusuf
    Ilgm, Sinem
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (05) : 1162 - 1168
  • [22] Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitors
    Dinges, Jurgen
    Akritopoulou-Zanze, Irini
    Arnold, Lee D.
    Barlozzari, Teresa
    Bousquet, Peter F.
    Cunha, George A.
    Ericsson, Anna M.
    Iwasaki, Nobuhiko
    Michaelides, Michael R.
    Ogawa, Nobuo
    Phelan, Kathleen M.
    Rafferty, Paul
    Sowin, Thomas J.
    Stewart, Kent D.
    Tokuyama, Ryukou
    Xia, Zhiren
    Zhang, Henry Q.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (16) : 4371 - 4375
  • [23] Unprecedented N → C[1,4] Boc migration: synthesis of 3-carboxyl functionalized 7-azaindolo[2,1-c][1,4]benzoxazine ring system
    Kurhade, Santosh
    Ramaiah, Parimi Atchuta
    Prathipati, Philip
    Bhuniya, Debnath
    TETRAHEDRON, 2013, 69 (04) : 1354 - 1362
  • [24] Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies
    Pingaew, Ratchanok
    Prachayasittikul, Veda
    Worachartcheewan, Apilak
    Nantasenamat, Chanin
    Prachayasittikul, Supaluk
    Ruchirawat, Somsak
    Prachayasittikul, Virapong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 103 : 446 - 459
  • [25] Discovery of substituted 1,4-dihydroquinolines as novel class of ABCB1 modulators
    Hemmer, Marc
    Krawczyk, Soeren
    Simon, Ina
    Lage, Hermann
    Hilgeroth, Andreas
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (15) : 5015 - 5021
  • [26] Convergent stereoselective synthesis of multiple sulfated GlcNα(1,4)GlcAβ(1,4) dodecasaccharides
    Tanaka, Hiroshi
    Tateno, Yusuke
    Takahashi, Takashi
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2012, 10 (48) : 9570 - 9582
  • [27] Synthesis and antitumor activities of novel 1,4-disubstituted phthalazine derivatives
    Zhang, Shulan
    Zhao, Yanfang
    Liu, Yajing
    Chen, Dong
    Lan, Weihuan
    Zhao, Qiaoling
    Dong, Chengcheng
    Xia, Lin
    Gong, Ping
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (08) : 3504 - 3510
  • [28] Synthesis and antitumor activities of novel 1,4-substituted phthalazine derivatives
    Zhang, Shu Lan
    Liu, Ya Jing
    Zhao, Yan Fang
    Guo, Qiu Ting
    Gong, Ping
    CHINESE CHEMICAL LETTERS, 2010, 21 (09) : 1071 - 1074
  • [29] Synthesis and SAR of b-Annulated 1,4-Dihydropyridines Define Cardiomyogenic Compounds as Novel Inhibitors of TGFβ Signaling
    Schade, Dennis
    Lanier, Marion
    Willems, Erik
    Okolotowicz, Karl
    Bushway, Paul
    Wahlquist, Christine
    Gilley, Cynthia
    Mercola, Mark
    Cashman, John R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (22) : 9946 - 9957
  • [30] Novel Enyne-Modified 1,4-Thiazepines as Epidermal Growth Factor Receptor Inhibitors: Anticancer and Computational Studies
    Atmaca, Harika
    Pulat, Cisil Camli
    Ilhan, Suleyman
    Yilmaz, Elif Serel
    Zora, Metin
    ACS OMEGA, 2024, 10 (01): : 821 - 832
12345